{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T08:30:44Z","timestamp":1793867444200,"version":"4.6.1"},"reference-count":40,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003132","name":"Agentschap voor Innovatie door Wetenschap en Technologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003323","name":"Agence Nationale de Recherches sur le Sida et les H\u00e9patites Virales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003323","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004385","name":"Universiteit Gent","doi-asserted-by":"publisher","award":["01G01712"],"award-info":[{"award-number":["01G01712"]}],"id":[{"id":"10.13039\/501100004385","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011878","name":"Vlaamse regering","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011878","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002749","name":"Belgian Federal Science Policy Office","doi-asserted-by":"publisher","award":["IUAP P7\/47-HEPRO-2"],"award-info":[{"award-number":["IUAP P7\/47-HEPRO-2"]}],"id":[{"id":"10.13039\/501100002749","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Antiviral Research"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/j.antiviral.2017.02.011","type":"journal-article","created":{"date-parts":[[2017,2,21]],"date-time":"2017-02-21T10:33:07Z","timestamp":1487673187000},"page":"150-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":53,"special_numbering":"C","title":["Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma"],"prefix":"10.1016","volume":"141","author":[{"given":"Ibrahim M.","family":"Sayed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9235-0814","authenticated-orcid":false,"given":"Lander","family":"Foquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieven","family":"Verhoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florence","family":"Abravanel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Farhoudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert","family":"Leroux-Roels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Izopet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Meuleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.antiviral.2017.02.011_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-0033-1338112","article-title":"Hepatitis E: clinical presentation in disease-endemic areas and diagnosis","volume":"33","author":"Aggarwal","year":"2013","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.antiviral.2017.02.011_bib2","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jhep.2016.01.011","article-title":"Human liver chimeric mice as a new model of chronic hepatitis E virus infection and preclinical drug evaluation","volume":"64","author":"Allweiss","year":"2016","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.antiviral.2017.02.011_bib3","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/vox.12156","article-title":"Serological and molecular evidence of a plausible transmission of hepatitis E virus through pooled plasma","volume":"107","author":"Andonov","year":"2014","journal-title":"Vox Sang."},{"key":"10.1016\/j.antiviral.2017.02.011_bib4","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/nbt1326","article-title":"Robust expansion of human hepatocytes in Fah-\/-\/Rag2-\/-\/Il2rg-\/- mice","volume":"25","author":"Azuma","year":"2007","journal-title":"Nat. Biotech."},{"key":"10.1016\/j.antiviral.2017.02.011_bib5","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1016\/j.jhep.2014.08.047","article-title":"The impact of hepatitis E in the liver transplant setting","volume":"61","author":"Behrendt","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.antiviral.2017.02.011_bib6","doi-asserted-by":"crossref","first-page":"20507","DOI":"10.1073\/pnas.0710528105","article-title":"Repopulation of adult and neonatal mice with human hepatocytes: a chimeric animal model","volume":"104","author":"Bissig","year":"2007","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2017.02.011_bib7","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1172\/JCI40094","article-title":"Human liver chimeric mice provide a model for hepatitis B and C virus infection and treatment","volume":"120","author":"Bissig","year":"2010","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.antiviral.2017.02.011_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.transci.2016.10.016","article-title":"Hepatitis E virus: emerging from the shadows in developed countries","volume":"55","author":"Dalton","year":"2016","journal-title":"Transfus. Apher. Sci."},{"key":"10.1016\/j.antiviral.2017.02.011_bib9","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3009512","article-title":"Broadly neutralizing antibodies abrogate established hepatitis C virus infection","volume":"6","author":"de Jong","year":"2014","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.antiviral.2017.02.011_bib10","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2014.08.040","article-title":"A\u00a0mutation in the hepatitis E virus RNA polymerase promotes its replication and associates with ribavirin treatment failure in organ transplant recipients","volume":"147","author":"Debing","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.antiviral.2017.02.011_bib11","doi-asserted-by":"crossref","first-page":"270","DOI":"10.3390\/v8100270","article-title":"Zoonotic hepatitis E virus: classification, animal reservoirs and transmission routes","volume":"8","author":"Doceul","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2017.02.011_bib12","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1186\/1475-2875-12-430","article-title":"Molecular detection and quantification of Plasmodium falciparum-infected human hepatocytes in chimeric immune-deficient mice","volume":"12","author":"Foquet","year":"2013","journal-title":"Malar. J."},{"key":"10.1016\/j.antiviral.2017.02.011_bib13","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1172\/JCI70349","article-title":"Vaccine-induced monoclonal antibodies targeting circumsporozoite protein prevent Plasmodium falciparum infection","volume":"124","author":"Foquet","year":"2014","journal-title":"J.\u00a0Clin. Investig."},{"key":"10.1016\/j.antiviral.2017.02.011_bib14","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1093\/jac\/dkv019","article-title":"Anti-CD81 but not anti-SR-BI blocks Plasmodium falciparum liver infection in a humanized mouse model","volume":"70","author":"Foquet","year":"2015","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.antiviral.2017.02.011_bib15","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/978-1-4939-2815-6_5","article-title":"Assessment of parasite liver-stage burden in human-liver chimeric mice","volume":"1325","author":"Foquet","year":"2015","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2017.02.011_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/978-1-4939-6506-9_8","article-title":"Successful Engraftment of Human Hepatocytes in uPA-SCID and FRG(R) KO Mice","volume":"1506","author":"Foquet","year":"2017","journal-title":"Methods Mol. Biol."},{"key":"10.1016\/j.antiviral.2017.02.011_bib17","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ng0895-453","article-title":"Pharmacological correction of neonatal lethal hepatic dysfunction in a murine model of hereditary tyrosinaemia type I","volume":"10","author":"Grompe","year":"1995","journal-title":"Nat. Genet."},{"issue":"11","key":"10.1016\/j.antiviral.2017.02.011_bib18","doi-asserted-by":"crossref","first-page":"299","DOI":"10.3390\/v8110299","article-title":"Acute Hepatitis E: Two Sides of the Same Coin","volume":"8","author":"Hartl","year":"2016","journal-title":"Viruses"},{"key":"10.1016\/j.antiviral.2017.02.011_bib19","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1016\/S0140-6736(14)61034-5","article-title":"Hepatitis E virus in blood components: a prevalence and transmission study in southeast England","volume":"384","author":"Hewitt","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.antiviral.2017.02.011_bib20","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1128\/JCM.42.11.5047-5052.2004","article-title":"Routes of Transmission of Swine Hepatitis E Virus in Pigs","volume":"42","author":"Kasorndorkbua","year":"2004","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2017.02.011_bib21","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S0166-0934(01)00420-7","article-title":"Use of a swine bioassay and a RT-PCR assay to assess the risk of transmission of swine hepatitis E virus in pigs","volume":"101","author":"Kasorndorkbua","year":"2002","journal-title":"J.\u00a0Virol. Methods"},{"key":"10.1016\/j.antiviral.2017.02.011_bib22","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1002\/hep.20657","article-title":"Morphological and biochemical characterization of a human liver in a uPA-SCID mouse chimera","volume":"41","author":"Meuleman","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2017.02.011_bib23","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.chom.2015.02.011","article-title":"Plasmodium vivax liver stage development and hypnozoite persistence in human liver-chimeric mice","volume":"17","author":"Mikolajczak","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.antiviral.2017.02.011_bib24","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1128\/JVI.02205-13","article-title":"Hepatitis E virus genotype 1 infection of swine kidney cells in\u00a0vitro is inhibited at multiple levels","volume":"88","author":"Nguyen","year":"2014","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.02.011_bib25","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/jvh.12500","article-title":"The expanding toolbox for hepatitis C virus research","volume":"23","author":"Ortega-Prieto","year":"2016","journal-title":"J.\u00a0Viral Hepat."},{"key":"10.1016\/j.antiviral.2017.02.011_bib26","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.1038\/emi.2013.9","article-title":"Pathobiology of hepatitis E: lessons learned from primate models","volume":"2","author":"Purcell","year":"2013","journal-title":"Emerg. Microbes Infect."},{"key":"10.1016\/j.antiviral.2017.02.011_bib27","doi-asserted-by":"crossref","first-page":"763","DOI":"10.2217\/fvl.15.29","article-title":"The emergence of hepatitis E virus in Europe","volume":"10","author":"Sayed","year":"2015","journal-title":"Future Virol."},{"key":"10.1016\/j.antiviral.2017.02.011_bib28","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.27990","article-title":"Is hepatitis E virus an emerging problem in industrialized countries?","volume":"62","author":"Sayed","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.antiviral.2017.02.011_bib29","article-title":"Study of hepatitis E virus infection of genotype 1 and 3 in mice with humanised liver","author":"Sayed","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2017.02.011_bib30","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1073\/pnas.1018878108","article-title":"Cross-species infections of cultured cells by hepatitis E virus and discovery of an infectious virus\u2013host recombinant","volume":"108","author":"Shukla","year":"2011","journal-title":"Proc. Natl. Acad. Sci."},{"key":"10.1016\/j.antiviral.2017.02.011_bib31","first-page":"29","article-title":"Modeling malaria in humanized mice: opportunities and challenges","volume":"1342","author":"Siu","year":"2015","journal-title":"Malar. Adv. Pathophysiol. Biol. Drug Dev."},{"key":"10.1016\/j.antiviral.2017.02.011_bib32","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1099\/vir.0.068429-0","article-title":"Consensus proposals for classification of the family Hepeviridae","volume":"95","author":"Smith","year":"2014","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2017.02.011_bib33","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1099\/vir.0.82535-0","article-title":"Development and evaluation of an efficient cell-culture system for Hepatitis E virus","volume":"88","author":"Tanaka","year":"2007","journal-title":"J.\u00a0Gen. Virol."},{"key":"10.1016\/j.antiviral.2017.02.011_bib34","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1128\/JCM.00629-09","article-title":"Development and characterization of a genotype 4 hepatitis E virus cell culture system using a HE-JF5\/15F strain recovered from a fulminant hepatitis patient","volume":"47","author":"Tanaka","year":"2009","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.antiviral.2017.02.011_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2015-311000","article-title":"In\u00a0vivo evidence for ribavirin-induced mutagenesis of the hepatitis E virus genome","author":"Todt","year":"2016","journal-title":"Gut"},{"key":"10.1016\/j.antiviral.2017.02.011_bib36","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/jmv.1890430207","article-title":"Infectivity titration of a prototype strain of hepatitis E virus in cynomolgus monkeys","volume":"43","author":"Tsarev","year":"1994","journal-title":"J.\u00a0Med. Virol."},{"key":"10.1016\/j.antiviral.2017.02.011_bib37","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1128\/JVI.00114-16","article-title":"Hepatitis E Virus (HEV) Genotype 3 Infection of Human Liver Chimeric Mice as a Model for Chronic HEV Infection","volume":"90","author":"van de Garde","year":"2016","journal-title":"J.\u00a0Virol."},{"key":"10.1016\/j.antiviral.2017.02.011_bib38","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2217\/fmb.12.27","article-title":"Development of humanized mouse models to study human malaria parasite infection","volume":"7","author":"Vaughan","year":"2012","journal-title":"Future Microbiol."},{"key":"10.1016\/j.antiviral.2017.02.011_bib39","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.jhep.2014.07.013","article-title":"HCV animal models and liver disease","volume":"61","author":"Vercauteren","year":"2014","journal-title":"J.\u00a0Hepatol."},{"key":"10.1016\/j.antiviral.2017.02.011_bib40","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.coviro.2015.04.009","article-title":"Animal models for the study of HCV","volume":"13","author":"Vercauteren","year":"2015","journal-title":"Curr. Opin. Virol."}],"container-title":["Antiviral Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216306696?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0166354216306696?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,26]],"date-time":"2022-06-26T05:50:57Z","timestamp":1656222657000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0166354216306696"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,5]]},"references-count":40,"alternative-id":["S0166354216306696"],"URL":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.02.011","relation":{},"ISSN":["0166-3542"],"issn-type":[{"value":"0166-3542","type":"print"}],"subject":[],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transmission of hepatitis E virus infection to human-liver chimeric FRG mice using patient plasma","name":"articletitle","label":"Article Title"},{"value":"Antiviral Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.antiviral.2017.02.011","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}